Loomis, Sayles & Company’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29M | Sell |
277,465
-6,705
| -2% | -$700K | 0.04% | 179 |
|
|
2025
Q1 | $33.1M | Sell |
284,170
-5,941
| -2% | -$693K | 0.05% | 153 |
|
|
2024
Q4 | $24.5M | Sell |
290,111
-8,475
| -3% | -$717K | 0.03% | 223 |
|
|
2024
Q3 | $26.8M | Buy |
298,586
+29,497
| +11% | +$2.65M | 0.04% | 219 |
|
|
2024
Q2 | $21.7M | Sell |
269,089
-10,702
| -4% | -$861K | 0.03% | 249 |
|
|
2024
Q1 | $22.3M | Buy |
+279,791
| New | +$22.3M | 0.03% | 244 |
|